Based on the aforementioned results, we speculated that QFY may exert its protective effect against bacterial pneumonia-induced lung injury by targeting gut microbiota to stimulate production of SCFAs that inhibit the NF-κB/NLRP3 axis. Here, NLRP3 is linked to bacterial pneumonia.